Literature DB >> 18697422

[Etiologic agents and risk factors in nosocomial urinary tract infections].

Seviç Akkoyun1, Figen Kuloğlu, Burcu Tokuç.   

Abstract

Nosocomial urinary tract infection (NUSI) is one of the most common hospital acquired infections. In this study, we aimed to determine the risk factors, frequency and the bacterial etiology of NUSI in hospitalized patients at Trace University Hospital, Turkey. Between September 1st 2004 to March 1st 2005, 104 NUSI episodes from 91 adult patients (mean age; 60.8 +/- 16.1 years; 46 were female) were determined among 8704 patients admitted to the hospital. During the study period, cumulative incidence of NUSI was 1.04% and episode rate of NUSI was 1.19%. The most important risk factors for NUSI were detected as urinary catheterization (78.8%), antimicrobial therapy within the previous 15 days (60.6%), fecal incontinence (33.7%) and surgical operations [29.8% (42% of them were urological pertainings)]. In 37.8% of the episodes urinary catheterization was considered as performed unnecessarily. In 26% of the episodes another infection (pneumoniae, abdominal infection, wound infection) accompanied. The causative microorganisms were resistant to the antibiotics used for therapy in 93.6% of the episodes. A total of 118 microorganisms (14 were polymicrobial) have been isolated from the urine cultures. The most frequently isolated ones were Escherichia coil (n: 48; 40.8%), Candida spp. (n: 27; 23%), Enterococcus spp. (n: 13; 11%), Pseudomonas aeruginosa (n: 9; 7.6%), Klebsiella pneumoniae (n: 8; 6.8%) and Acinetobacter spp. (n: 5; 4.2%). The highest susceptibility rates of E. coli isolates were against imipenem and nitrofurantoin (100%) and amikacin (97.7%), the lowest susceptibility rates were against ampicillin (26.7%) and amoxycillin-clavulonate (44.4%). No glycopeptid resistance was detected for Enterococcus spp. while the susceptibility rates to penicilin and nitrofurantoin were 38.5% and 63.6%, respectively. Since the number of the other bacterial species was low (<10) their antimicrobial resistance rates were not evaluated. Extended-spectrum beta-lactamase (ESBL) production was determined in 27% of E. coli and in 25% of K. pneumoniae isolates, and cases with ESBL producing strains had significiantly higher antibiotic consumption rate in the previous 15 days (p = 0.004). Blood cultures which were collected during NUSI episodes yielded positive results in 31.8%. The mortality rate due to NUSI was significantly higher in cases with bloodstream infection (p = 0.000). In conclusion, the high rates of NUSI associated with bloodstream infections and mortality detected have pointed out serious problems in our hospital, and indicated that more attention should be paid on urinary catheterisation, rational antibiotic usage and control of nosocomial infections.

Entities:  

Mesh:

Year:  2008        PMID: 18697422

Source DB:  PubMed          Journal:  Mikrobiyol Bul        ISSN: 0374-9096            Impact factor:   0.622


  4 in total

1.  [Profile of nosocomial urinary tract infection in a nephrology ward].

Authors:  Mohamed Amine Lazrak; Ghita El Bardai; Soumia Jaafour; Nadia Kabbali; Mohamed Arrayhani; Tarik Sqalli Houssaini
Journal:  Pan Afr Med J       Date:  2014-09-23

2.  Isolation of enterococci, their antimicrobial susceptibility patterns and associated factors among patients attending at the University of Gondar Teaching Hospital.

Authors:  Amelework Yilema; Feleke Moges; Sisay Tadele; Mengistu Endris; Afework Kassu; Wondwossen Abebe; Getnet Ayalew
Journal:  BMC Infect Dis       Date:  2017-04-17       Impact factor: 3.090

3.  Geriatric urinary tract infections: The value of laboratory parameters in estimating the need for bacteremia and Intensive Care Unit.

Authors:  Ayse Sagmak Tartar; Safak Ozer Balin
Journal:  Pak J Med Sci       Date:  2019 Jan-Feb       Impact factor: 1.088

4.  Magnitude of Vancomycin-Resistant Enterococci (VRE) Colonization among HIV-Infected Patients Attending ART Clinic in West Amhara Government Hospitals.

Authors:  Manamenot Agegne; Bayeh Abera; Awoke Derbie; Gizachew Yismaw; Melashu Balew Shiferaw
Journal:  Int J Microbiol       Date:  2018-12-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.